Lisa D. MacDonald

Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients

Neil L. Berinstein, Mohan Karkada, Amit M. Oza et al. · OncoImmunology · 2015 · 98 citations · Full text

First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients

Neil L. Berinstein, Mohan Karkada, Michael A. Morse et al. · Journal of Translational Medicine · 2012 · 84 citations · Full text

A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans Study

Joanne M. Langley, Lisa D. MacDonald, Genevieve Weir et al. · The Journal of Infectious Diseases · 2018 · 55 citations · Full text

Rejection of large HPV-16 expressing tumors in aged mice by a single immunization of VacciMax® encapsulated CTL/T helper peptides

Pirouz Daftarian, Marc Mansour, Bill Pohajdak et al. · Journal of Translational Medicine · 2007 · 40 citations · Full text

A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses

Mohan Karkada, Genevieve Weir, Tara Quinton et al. · Journal of Immunotherapy · 2010 · 34 citations

Vaccination, Mucosal Vaccination, Radiation Oncology +15